In short. Ke He, MD is a physician at Chongqing West District Hospital, where she leads the injectable content on this site and practises assessment-led, conservative aesthetic medicine.
Key points
- Under-treatment is not indecision; it is a plan with a second step built into it.
- Every injectable changes over the following weeks, so the honest route to a settled result is to treat conservatively, let the tissue settle, and refine at review.
Ke He, MD is a physician at Chongqing West District Hospital, a tertiary general hospital in Jiulongpo District, Chongqing. She is Deputy Director of the hospital’s Plastic Surgery & Aesthetics Medical Center and head of its skin and laser aesthetic service, and the lead physician for the injectable content on this site.
A four-physician team at Chongqing West District Hospital
Dr. He works in a four-physician team. Shaoliang Wang is the Center Director; Tongchun Mao and Yongbo Jia complete the group alongside her. Because the centre covers surgical and non-surgical care, a patient whose concern is not served by an injection can be referred internally rather than sent away.
What she treats, by substance class
Her injectable scope is described by substance class rather than product name. Botulinum toxin is used for dynamic lines and for facial slimming where muscle bulk is the cause. Hyaluronic-acid and non-hyaluronic-acid dermal fillers restore volume and refine contour. Collagen stimulators and biostimulators work towards the patient’s own tissue response over time, skin boosters address skin quality rather than shape, and thread lifts are considered for selected cases only.
How she works
Consultation and facial assessment come first, and they take time. She examines the face at rest and in movement, notes asymmetry, assesses volume loss by zone, skin quality and tissue laxity, and reviews previous treatments and medical history before any plan is discussed. Treatment is then staged across visits. The guiding principle is deliberate under-treatment: adding a little at review is easier than correcting too much.
Under-treat first, refine at review
Under-treatment is not indecision; it is a plan with a second step built into it. Every injectable changes over the following weeks, so the honest route to a settled result is to treat conservatively, let the tissue settle, and refine at review.
Safety inside a tertiary general hospital
Practising inside a tertiary general hospital changes the safety context. Sterile procedure rooms, hospital pharmacy support and emergency response stand behind every injection, so a vascular emergency — filler blocking a vessel, a time-critical event that carries a risk of skin loss and, in the worst case, vision loss — can be assessed and treated on site. That does not remove risk; it changes how fast risk can be managed.
Honest limits
Every injectable is temporary to some degree, and none is risk-free. No physician can guarantee a particular look. Results vary with anatomy, healing and time, and the same treatment given to two patients will not look identical on both.
What “verifiable” means on this site
This site publishes only what a patient could independently confirm: her name, her hospital, her role within the centre and the scope of her practice. Her academic memberships and professional record are listed with her full profile on the doctors page, and nothing beyond what the hospital can document is claimed anywhere on this site.
Book a consultation rather than self-prescribe
- You have a specific feature you want changed and you have already decided which substance should change it.
- You have had a previous injectable elsewhere and do not have a clear record of what was used, where or when.
- You have a medical condition, take regular medication, are pregnant or breastfeeding, or have had a reaction to an injection before.
Frequently asked questions
Who assesses and treats patients in this practice?
Dr. He leads the injectable content on this site and works inside a four-physician team at Chongqing West District Hospital. She examines the face at rest and in movement, notes asymmetry and volume loss by zone, reviews medical history and previous treatments, and stages treatment across visits.
Which injectable substance classes does she use?
Botulinum toxin for dynamic lines and muscle-driven contour, hyaluronic-acid and non-hyaluronic-acid dermal fillers for volume and contour, collagen stimulators and biostimulators, skin boosters for skin quality rather than shape, and thread lifts in selected cases only.
What does under-treatment mean in practice?
It means treating conservatively at the first session and refining at review rather than correcting an excess afterwards. Every injectable changes over the following weeks, so the settled result is reached in steps, and a second visit is built into the plan.
Risks & Limitations
- Vascular occlusion — a time-critical emergency in which filler blocks a blood vessel. It can cause skin loss and, rarely, blindness.
- Nodules, lumps or granuloma formation, which may need treatment or dissolution.
- Infection at the injection site.
- Asymmetry or over-correction; over-treatment is harder to correct than under-treatment.
- Migration of filler away from the intended area.
- Temporary brow or eyelid droop after botulinum toxin, which resolves as the effect wears off.
- Bruising and swelling. All injectable results are temporary and maintenance is required.
When to Seek Care
- Severe pain out of proportion to the procedure, or skin turning white, grey, mottled or dusky — this is a vascular emergency; seek care immediately.
- Any change in vision — seek emergency care immediately.
- Fever, spreading redness, warmth or pus at an injection site.
- A hard, painful lump that is growing.
- Drooping eyelid, difficulty swallowing, or difficulty breathing after botulinum toxin.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable safety information
- American Society of Plastic Surgeons (ASPS) — injectable guidance
- U.S. Food and Drug Administration (FDA) — approved filler and neurotoxin products
- National Medical Products Administration (NMPA, China) — approved product status
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.